ContraFect Corporation (NASDAQ:CFRX) does about 4.14M shares in volume on a normal day but saw 22882995 shares change hands in Monday trading. The company now has a market cap of 4.08M USD. Its current market price is $0.09, marking a decrease of -0.44% compared to the previous close of $0.09. The 52 week high reached by this stock is $4.54 whilst the lowest price level in 52 weeks is $0.08. The script in recent trading has seen the stock touch a high of $0.096 and a low of $0.088.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
ContraFect Corporation (CFRX) has a 20-day trading average at $0.0974 and the current price is -98.00% off the 52-week high compared with 9.16% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.1199 and its 200-day simple moving average is $1.2899. If we look at the stock’s price movements over the week, volatility stands at 14.87%, which decreases to 12.66% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 35.17 to suggest the stock is neutral.
1 analysts observing the ContraFect Corporation (CFRX) stock have set the 12-month price targets for the company’s shares at between $3.00 and $3.00. The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 98.2% over the period. The median price target is 97.0% away from the current levels at $3.00.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 14, 2022 when SVB Leerink downgraded the stock to “Mkt Perform” and issued a price target of $1. Cantor Fitzgerald also downgraded the stock to “Neutral” from Overweight on July 14, 2022 at a price target of $15-$1. WBB Securities upgraded its price target at $6.50.
The current price level is -7.59%, -25.08%, and -93.08% away from its SMA20, SMA50, and SMA200 respectively, with the CFRX price moving above the 50-day SMA on January 23. ContraFect Corporation (CFRX) stock is down -10.30% over the week and -13.30% over the past month. Its price is -5.63% year-to-date and -96.29% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of -$0.43 below consensus estimates by -$0.2. The company’s next earnings report is expected on 05/12/2023, with forecasts estimating quarterly EPS at -$0.34 and -$1.55 for whole year. CFRX’s earnings per share are forecast to shrink by -181.80% this year and 14.20% over next year.
Its 12-month price target is $3.00. To reach the target analysts have set, the stock logically needs to grow 98.2 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $3.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $3.00.
Outstanding shares total 39.33M with insiders holding 4.39% of the shares and institutional holders owning 30.45% of the company’s common stock. The company has a return on equity of -267.90%. The beta has a value of 0.40.
According to a U.S. Securities and Exchange Commission filing, Vanguard Extended Market Index Fu has added its position in ContraFect Corporation (CFRX) to 423,968 shares, mirroring a recent increase by 0.18%. Vanguard Extended Market Index Fu added 756.0 shares of ContraFect Corporation common stock bringing its total worth to about $40701.0 at the end of recent close, SEC documents show.
